HIGHLIGHTS
- who: Schneider JE and colleagues from the Avalon Health Economics, Morristown, NJ, USA have published the research work: Impact of Novel Insulin Management Service on Non-insulin Pharmaceutical Expenses, in the Journal: (JOURNAL)
- what: Objectives: This study examined the use of insulin management services to enable patients to optimize insulin dosing to achieve HbA1c targets and subsequently reduce health care costs. The aim of this study was to assess the ability of an insulin management service to reduce costs associated with the use of expensive diabetes drugs in a usual care setting within the U . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.